University of New South Wales
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of New South Wales
Genentech will use the X-Chem platform to obtain leads against multiple oncology targets. Lilly partners with Merus on CD3-targeting T-cell therapy candidates.
Brief summaries of recent advances in device research and clinical trials, including an implantable sensor designed to measure cancer progression and treatment, new findings on angiogenesis-suppressing genes that protect Down's syndrome patients from cancer, research that implacates two inflammation-related proteins in breast cancer outcomes, and stem-cell implanted contact lenses that repair corneal damage.
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- Academic and Research Institutions